Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

October 22, 2024

Insulet to expand with 110 new jobs in Mass., as Watertown life sciences firm looks to add 20

Photo | Courtesy of Insulet Insulet's headquarters in Acton

Two Central Massachusetts life sciences companies are expanding their presence in the state, committing to a total of 130 new jobs as part of a state tax incentive program designed to bolster the life sciences industry.

Acton-based medical device manufacturer Insulet received $1.92 million with a commitment to create 110 jobs, according to an Oct. 15 joint press release from the office of Gov. Maura Healey and the Massachusetts Executive Office of Economic Development.

The majority of Insulet’s new positions will be in manufacturing, including engineering and quality technician jobs with additional roles in sales and marketing; research and development; and customer support. Having already started its hiring process, Insulet plans to spend a portion of its funding on employee training, Angela Geryak Wiczek, Insulet senior director, corporate communications, said in a Monday email to WBJ. 

Watertown-based EyePoint Pharmaceuticals received $500,000 with a commitment to create 20 jobs.

EyePoint’s incentive funding will be used to create jobs primarily in manufacturing, supply chain, quality, and engineering at the company’s 40,000-square-foot commercial manufacturing facility in Northbridge, Jay Duker, EyePoint President and CEO, wrote in an Oct. 17 email to WBJ. EyePoint is actively recruiting for the 20 positions and expects to continue into 2025. 

The awards are provided through the Massachusetts Life Sciences Center’s Tax Incentive program, providing funding to life sciences research and development, commercialization and manufacturing firms throughout the state, according to MLSC’s website. The funds are jointly administered by the Tax Incentive program and the Massachusetts Department of Revenue, which is responsible for the technical administration of the awards.

The tax breaks for Insulet and Eyepoint were among 19 awards totalling $21.4 million in state tax incentives, meant to promote the creation of 1,155 total new life sciences industry jobs.

In order to qualify for the incentives, applicants must have been registered in Massachusetts, employ at least 10 permanent full time equivalent state employees as of Dec. 31, 2023, pledge to hire at least 10 net new jobs in calendar year 2024 and commit to their retention through Dec. 31, 2028. 

Awarded companies will be subject to routine reporting requirements to document their job creations and retention.

“We must continue to meet the moment and send a strong signal to companies here in Massachusetts and globally that our state remains the best place in the world to launch and scale life sciences solutions,” Healey said in the release. “Becoming the global hub of the life sciences doesn’t happen by accident. These awards will allow our state to accelerate innovation and job creation and transform lives around the world.”

Mica Kanner-Mascolo is a staff writer at Worcester Business Journal, who primarily covers the healthcare and diversity, equity, and inclusion industries.

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF